Gland Pharma consolidated net profit declines 25.94% in the June 2024 quarter

Net profit of Gland Pharma declined 25.94% to Rs 143.76 crore in the quarter ended June 2024 as against Rs 194.10 crore during the previous quarter ended June 2023. Sales rose 15.97% to Rs 1401.71 crore in the quarter ended June 2024 as against Rs 1208.69 crore during the previous quarter ended June 2023.

Particulars	Quarter Ended
	Jun. 2024	Jun. 2023	% Var.
Sales	1401.71	1208.69	16
OPM %	18.86	24.32	-
PBDT	310.21	326.58	-5
PBT	218.25	261.27	-16
NP	143.76	194.10	-26